NovaTechs: Where Ideas Save Lives

We are here to revolutionize interventional radiology, with a focus on transcatheter embolization— a vital technique for addressing hypervascular tumors and cutting off their blood supply.

Discover Our Innovative Gel Solutions

Learn How Our Gels Can Change Patients' Health

2020

Founded in Netherlands

2023

NovaSeal™ Launched

2025

First Meeting with FDA

Overview of Technology

Novel hydrogel solution for interventional radiology

Our in situ gelling system is injected as a liquid and rapidly transforms into a gel in response to body temperature. This allows for precise vessel occlusion, deep penetration, and minimized off-target effects, making it ideal for embolization.

It also enables localized, sustained drug release, supporting targeted delivery of chemo, radio, or immuno-therapeutics with reduced systemic side effects.

In situ gelation

Precise embolization

Sustained drug delivery

Bio-based materials

NovaSeal™

An innovative embolic agent

Our flagship liquid embolic agent designed to revolutionize cancer treatment. NovaSeal stands at the intersection of innovation and compassion, engineered to provide targeted therapy that minimizes collateral damage to healthy tissues while maximizing therapeutic impact on tumors.

Ready-to-use

No complex preparation required

Efficient treatment

deeper vessel penetration

Non-toxic

No heavy metals or toxic solvents

Learn More About NovaSeal™

Biocompatible & Biodegradable

Real-time Monitoring

Minimally Invasive

Partners

Building strong partnerships to advance interventional radiology technology

Maastricht University

Leading research in biomedical engineering and drug delivery systems

Biomedical Engineering Drug Delivery

Eindhoven University of Technology

Expertise in polymer science and material development

Polymer Science Materials

University of Amsterdam

Research in interventional radiology and clinical applications

Interventional Radiology Clinical Research

Search NovaTechs